How physicians approach hereditary angioedema: a single center study
- PMID: 36452014
- PMCID: PMC9669465
- DOI: 10.5415/apallergy.2022.12.e40
How physicians approach hereditary angioedema: a single center study
Abstract
Background: Hereditary angioedema (HAE) is a rare autosomal dominant disorder caused by C1-inhibitor deficiency. It is characterized by recurrent attacks of cutaneous and upper respiratory tract swelling, and abdominal pain due to mucosal edema. Early detection and treatment prevent unnecessary interventions, improves quality of life, and prevents potentially fatal attacks.
Objective: The present study aims to investigate physicians level of knowledge and awareness regarding HAE.
Methods: A questionnaire about HAE was applied to 393 physicians from a university hospital. Participants were requested to choose one or several answers to multiple-choice questions.
Results: Seven and three tenths percent of study participants stated to have never heard of HAE. Twenty-seven physicians (7.4%) chose the exact correct answers regarding diagnostic tests, and 2 (0.8%) chose the exact correct answers regarding emergency management. A composite of internists, pediatrists and emergency medicine specialists had a significantly higher mean score than other physicians (p = 0.047). Physicians from internal medical sciences scored significantly higher than physicians from surgical medical sciences (p = 0.022).
Conclusion: The present study reveals that physician awareness about HAE is low, and physicians misdiagnose HAE attacks as histaminergic angioedema attacks, and therefore provide ineffective treatment. Although HAE is a rare disease, physician awareness must be increased, because early diagnosis and effective treatment are vital for the patients.
Keywords: Angioedema; Complement-C1 inhibitor protein; Disease awareness; Doctors; Hereditary angioedema.
Copyright © 2022. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.
Conflict of interest statement
Conflict of Interest: The authors have no financial conflicts of interest.
Figures
Similar articles
-
The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures.Allergy Asthma Clin Immunol. 2018 Oct 25;14:75. doi: 10.1186/s13223-018-0275-4. eCollection 2018. Allergy Asthma Clin Immunol. 2018. PMID: 30386388 Free PMC article.
-
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study.Allergy Asthma Proc. 2024 Jul 1;45(4):247-254. doi: 10.2500/aap.2024.45.240021. Allergy Asthma Proc. 2024. PMID: 38982603 Free PMC article.
-
Diagnosis and screening of patients with hereditary angioedema in primary care.Ther Clin Risk Manag. 2016 May 2;12:701-11. doi: 10.2147/TCRM.S86293. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27194914 Free PMC article. Review.
-
The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.Postgrad Med. 2021 Aug;133(6):639-650. doi: 10.1080/00325481.2021.1905364. Epub 2021 Jul 6. Postgrad Med. 2021. PMID: 33993830 Review.
-
Canadian physician survey on the medical management of hereditary angioedema.Ann Allergy Asthma Immunol. 2018 Nov;121(5):598-603. doi: 10.1016/j.anai.2018.06.017. Epub 2018 Jun 26. Ann Allergy Asthma Immunol. 2018. PMID: 29958877
Cited by
-
Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future.World Allergy Organ J. 2025 May 14;18(6):101060. doi: 10.1016/j.waojou.2025.101060. eCollection 2025 Jun. World Allergy Organ J. 2025. PMID: 40487881 Free PMC article. Review.
-
Asia Pacific Allergy: Asia Pacific and beyond.Asia Pac Allergy. 2022 Oct 31;12(4):e46. doi: 10.5415/apallergy.2022.12.e46. eCollection 2022 Oct. Asia Pac Allergy. 2022. PMID: 36452010 Free PMC article. No abstract available.
References
-
- Longhurst H, Cicardi M. Hereditary angio-oedema. Lancet. 2012;379:474–481. - PubMed
-
- Longhurst HJ, Bork K. Hereditary angioedema: an update on causes, manifestations and treatment. Br J Hosp Med (Lond) 2019;80:391–398. - PubMed
-
- Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, Farkas H, Grumach A, Kaplan AP, Riedl MA, Triggiani M, Zanichelli A, Zuraw B HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69:602–616. - PubMed
-
- Betschel S, Badiou J, Binkley K, Borici-Mazi R, Hébert J, Kanani A, Keith P, Lacuesta G, Waserman S, Yang B, Aygören-Pürsün E, Bernstein J, Bork K, Caballero T, Cicardi M, Craig T, Farkas H, Grumach A, Katelaris C, Longhurst H, Riedl M, Zuraw B, Berger M, Boursiquot JN, Boysen H, Castaldo A, Chapdelaine H, Connors L, Fu L, Goodyear D, Haynes A, Kamra P, Kim H, Lang-Robertson K, Leith E, McCusker C, Moote B, O’Keefe A, Othman I, Poon MC, Ritchie B, St-Pierre C, Stark D, Tsai E. The International/Canadian Hereditary Angioedema Guideline. Allergy Asthma Clin Immunol. 2019;15:72. - PubMed
-
- Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161:2417–2429. - PubMed
LinkOut - more resources
Full Text Sources